Click on the links or scroll down the page for information about work currently in progress by category. Please note that information summarised on this page is subject to change.
We produce prescribing guidance and other medicines resources to help patients and healthcare professionals in Wales make sure that medicines are used effectively and appropriately. When we produce these resources, we think it's important that people who might be affected by them have a chance to tell us their views. We ask patients and carers, patient organisations, prescribers and other healthcare professionals to comment on the resources we're developing. We'd like your views on the resources we're currently working on, listed below. You don't need to comment on the whole document; only on parts that seem relevant to you.
|
Title: Wales General Ophthalmic Services signed orders formulary Status: Consultation open Remit: The aim of this document is to agree an approved list of eye preparations (medicines and devices) for inclusion on the WGOS signed orders formulary. Estimated publication date: September-November 2025 |
|
Title: All Wales Medicine Management Guidelines for Integrated Community Based Services Status: Consultation completed Remit: This guideline is focused on community care and designed to address the unique needs and challenges faced by registered service providers ensuring consistent medicine advice in diverse care settings. Specifically designed to guide local policy development, this guideline aims to establish a unified and integrated policy across health and social care, providing comprehensive guidance for medicine optimisation. Estimated publication date: September-November 2025 |
|
Title: All Wales Shared Care Framework Status: Consultation completed Remit: To review and refine the current principles for the use of shared care within NHS Wales and to develop an All Wales framework that sets out the principles of shared care and supports health boards and prescribers in the appropriate use of shared care. Estimated publication date: June 2025-August 2025 |
|
Title: All Wales Common Ailments Service Formulary - Monograph for back pain Status: Consultation completed Remit: The Common Ailments Service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. The Welsh Medicines Advice Service (WMAS), in collaboration with the Community Pharmacy Clinical Advisory Group, have updated the back pain monograph to reflect the NICE Clinical Knowledge Summary update of October 2024, which incorporates the NICE guidance [NG234] on Spinal metastases and metastatic spinal cord compression. Estimated publication date: June 2025-August 2025 |
|
Medicines being considered will be listed here one week before the next Scrutiny Panel meeting on 7 August 2025 |
Patients, carers and patient organisations - please see our New medicines needing your views page for answers to some questions you might have about making a submission.
Clinical experts - please see our Clinical expert opinion for medicine appraisals page for background information.
We'd like to receive your submission before the stated deadline (so we can prepare the meeting papers). But we'll still try to include any that arrive late.
|
Medicine name: infliximab Reference number: OW31 Indication: For the off-label treatment of Immune Checkpoint Inhibitor (ICI) induced grade 3-4 myocarditis that has not responded to first line immunosuppression with corticosteroids. Patient organisation/patient/carer submission: Submit your response by email to awttc@wales.nhs.uk Clinical experts submission: Submit your response by email to awttc@wales.nhs.uk Submission deadline: 01/07/2025 OWMAG date: 11/08/2025 AWMSG date: 10/09/2025 |
|
Medicine name: venetoclax (Venclyxto®) plus azacitidine Reference number: OW32 Indication: Off-label treatment of relapsed / refractory (R/R) acute myeloid leukaemia (AML) following at least one line of intensive chemotherapy – this includes scenarios of molecular relapse, and relapse following allogeneic haematopoietic stem cell transplant [HSCT]) in situations where:
Patient organisation/patient/carer submission: Submit your response by email to awttc@wales.nhs.uk Clinical experts submission: Submit your response by email to awttc@wales.nhs.uk Submission deadline: 01/09/2025 OWMAG date: 06/10/2025 AWMSG date: 05/11/2025 |
|
Title: AWMSG annual report 2024-2025 Summary: Review of the activities and achievements of the All Wales Medicine Strategy Group (AWMSG) between April 2023 and March 2024. Estimated publication date: September 2025 |
|
Title: IPFR annual report 2024-2025 Summary: Review of Individual Patient Funding Request activity in Wales between April 2023 and March 2024. Estimated publication date: September 2025 |